Anson Funds Management LP Mei Pharma, Inc. Transaction History

Anson Funds Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 19, 2023	BUY	$0.21 - $0.35 $2.78 Million - $4.64 Million	13,250,582 New	13,250,582 $3.05 Million
Q4 2022 Feb 13, 2023	BUY	$0.22 - $0.41 $1.32 Million - $2.46 Million	6,007,536 Added 130.3%	10,617,959 $2.55 Million
Q2 2022 Aug 15, 2022	BUY	$0.42 - $0.65 $487,457 - $754,399	1,160,614 Added 33.64%	4,610,423 $2.79 Million
Q1 2022 May 12, 2022	BUY	$0.54 - $2.74 $352,781 - $1.79 Million	653,299 Added 23.36%	3,449,809 $2.08 Million
Q4 2021 Feb 14, 2022	BUY	$2.33 - $3.37 $6.52 Million - $9.42 Million	2,796,510 New	2,796,510 $7.47 Million

Ticker MEIP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 133,261,000
Market Cap $373M
Description
MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...

Get notified when there are updates to the investment portfolio of Anson Funds Management LP, based on Form 13F filings with the SEC.

Stay updated on Anson Funds Management LP with notifications on news.